MetabolicRetatrutide
GIP / GLP-1 / Glucagon Receptor Agonist · LY3437943
Investigational GIP / GLP-1 / glucagon receptor agonist for metabolic research.
EU Delivery: 2–4 Business Days
About this peptide
Retatrutide (LY3437943) is an investigational peptide agonist of the GIP, GLP-1 and glucagon receptors. It is being studied for its effects on metabolic signalling, glucose regulation, energy balance and body-weight regulation.
Retatrutide (LY3437943) is an investigational peptide agonist of the GIP, GLP-1 and glucagon receptors. It is being studied for its effects on metabolic signalling, glucose regulation, energy balance and body-weight regulation.
Research profile
Agonist activity at GIP, GLP-1 and glucagon receptors.
Investigated in glucose and lipid metabolism research.
Studied for its effects on energy intake and expenditure.
Investigated in clinical and preclinical metabolic research.
Research areas
- Metabolic signalling research
- Glucose regulation studies
- Energy balance research
- Body-weight regulation studies
Specifications
- Class
- GLP-1 / GIP / Glucagon triagonist
- Presentation
- 10 mg lyophilised vial
- Analytical
- Batch tested · HPLC verified
- Storage
- 2–8 °C, protect from light
Verified customer reviews
No reviews yet. Reviews come only from customers with a delivered order.
For research use only. Not intended for human or veterinary therapeutic use.
